GBS  logo

Quarterly report 2025-Q4
added 02-12-2026

report update icon

GBS Balance Sheet 2011-2026 | GBS

Annual Balance Sheet GBS

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-4.38 M -958 K - - 4.71 M 4.93 M 4.42 M 3.48 M - - - - - -

Long Term Debt

- 1.65 M 356 K - - - - - - - - - - - -

Long Term Debt Current

84.7 K 275 K 223 K - - - - - - - - - - - -

Total Current Liabilities

5.35 M 5.45 M 5.88 M 4.66 M 3.68 M - - - - - - - - - -

Total Liabilities

5.44 M 5.6 M 6.67 M 5.81 M 6.85 M 7.69 M 6.31 M 5.56 M 6.58 M - - - - - -

Retained Earnings

-62.5 M -52 M -41.8 M -31.2 M -22.9 M -15.8 M -12.7 M -5.33 M -312 K - - - - - -

Total Assets

8.25 M 13.8 M 10.4 M 12.4 M 21.9 M 2.48 M 2.33 M 2.5 M 667 K - - - - - -

Cash and Cash Equivalents

1.02 M 6.3 M 1.54 M 8.24 M 12.6 M - - - - - - - - - -

Book Value

2.81 M 8.18 M 3.69 M 6.55 M 15 M -5.21 M -3.98 M -3.06 M -5.91 M - - - - - -

Total Shareholders Equity

3 M 8.33 M 3.8 M 6.62 M 15.1 M -5.21 M - - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet GBS

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.53 M 1.45 M - 3.7 K 14.5 K 28.1 K 81.3 K 154 K 229 K 284 K 356 K 321 K 357 K - 500 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

6.76 M 6.61 M 5.44 M 4.64 M 4.48 M 5.78 M 5.6 M 6.04 M 5.67 M 7.46 M 6.67 M 4.74 M 7.78 M - 5.81 M 5.66 M 5.19 M 5.61 M 6.85 M 6.85 M 1.18 M 7.69 M 7.69 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-68.2 M -65.5 M -62.5 M -59.4 M -56.9 M -54.6 M -52 M -49.2 M -46.2 M -44.2 M -41.8 M -39.1 M -32.8 M - -31.2 M -29.1 M -27.8 M -24.3 M -22.9 M -22.9 M -18.9 M -15.8 M -15.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

17.7 M 10 M 8.25 M 9.58 M 8.68 M 11.7 M 13.8 M 17 M 8.83 M 8.7 M 10.4 M 10.7 M 18 M - 12.4 M 14.4 M 15.2 M 19.1 M 21.9 M 21.9 M 20 M 2.48 M 2.48 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

740 K 1.66 M 1.02 M 2.81 M 2.24 M 3.99 M 6.3 M 9.4 M 1.12 M 186 K 1.54 M 2.28 M 2.91 M - 8.24 M 10.8 M 11.2 M 12.6 M 12.6 M 12.6 M 19.9 M 427 K 427 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

10.9 M 3.43 M 2.81 M 4.94 M 4.2 M 5.95 M 8.18 M 11 M 3.15 M 1.24 M 3.69 M 5.93 M 10.3 M - 6.55 M 8.7 M 10 M 13.5 M 15 M 15 M 18.8 M -5.21 M -5.21 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

11.1 M 3.62 M 3 M 5.11 M 4.2 M 5.95 M 8.33 M 11 M 3.15 M 1.24 M 3.8 M 5.93 M 10.3 M 5.2 M 6.62 M 8.7 M 10 M 13.5 M 15 M 15.1 M 18.8 M -5.19 M -5.19 M -5.88 M -5.87 M -3.89 M -3.98 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of GBS , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 32.93 - $ 23.8 B britainBritain
Penumbra Penumbra
PEN
$ 338.24 - $ 13.2 B usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
Zynex Zynex
ZYXI
- - $ 21.1 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 108.49 - $ 189 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada